The Latest Cardiac and Vascular News
SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc. a fully integrated regenerative medicine company, today announced completion of patient enrollment in SECURE, a prospective post market study of 1,000 patients treated with CanGaroo® ECM® Envelope in conjunction with cardiac implantable electronic device (CIED) placement. […]
This study recaps one year and 1200 patients including use of the Diamond Back 360. Cardiovascular Systems touts 1-year, sub-analysis data from Liberty PVI study AUGUST 10, 2017 BY FINK DENSFORD, MassDevice Cardiovascular Systems (NSDQ:CSII) today released both 1-year and a sub-analysis results from […]
By Ken Dropiewski One of the pernicious effects of cardiovascular disease is that it creates scar tissue on the heart, which in turn disrupts normal pumping of a person’s blood, a phenomenon that can lead to heart failure due to […]
PCRonline/News/Industry Press Releases Med Alliance has announced completion on schedule of patient enrolment in the First-in-Man (FIM) study of SELUTION™, a novel sirolimus-coated balloon. 50 patients have been enrolled between 26 October 2016 and 23 May 2017 across four German […]
GlobalNewsWire DUBLIN – May 24, 2017 – Medtronic plc (NYSE: MDT) today announced that the first patient has been enrolled in the IN.PACT(TM) AV Access Drug-Coated Balloon (DCB) study for use in patients with end-stage renal disease (ESRD). The U.S. […]
Study met its primary endpoint with PFO closure in conjunction with antiplatelet therapy, reducing recurrent stroke by > 75% over antiplatelet therapy alone Share: Twitter Linked In Source W. L. Gore Press Release FLAGSTAFF, Ariz. (May 16, 2017) – W. L. […]
MUNICH, April 27, 2017 /PRNewswire/ — ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients following successful transcatheter aortic valve implantation Study adds to the growing […]
PCRonline/News/Industry Press Releases – 04 April, 2017 MASTER-DAPT kicks-off with the enrolment of its first patient by Treant Zorggroep, Scheper Hospital Emmen, The Netherlands – Dr Gillian Jessurun from Treant Zorggroep, Scheper Hospital has enrolled the first patient in the investigator […]
Mar 31, 2017 – IRVINE, Calif.–(BUSINESS WIRE)– Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the first patients were treated in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft […]
